Tg Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tg Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $17M | 721k | 23.39 |
2024-06-30 | $8.0M | 451k | 17.79 |
2024-03-31 | $5.5M | 365k | 15.21 |
2023-12-31 | $4.6M | 267k | 17.08 |
2023-09-30 | $1.7M | 205k | 8.36 |
2023-06-30 | $6.8M | 275k | 24.84 |
2023-03-31 | $3.5M | 235k | 15.01 |
2022-12-31 | $3.4M | 288k | 11.83 |
2022-06-30 | $1.2M | 291k | 4.25 |
2022-03-31 | $2.6M | 269k | 9.51 |
2021-12-31 | $5.1M | 260k | 19.61 |
2021-03-31 | $8.5M | 175k | 48.20 |
2020-12-31 | $8.3M | 160k | 52.05 |
2020-09-30 | $4.6M | 177k | 26.08 |
2020-06-30 | $3.6M | 184k | 19.49 |
2020-03-31 | $2.0M | 205k | 9.75 |
2019-12-31 | $2.8M | 253k | 11.03 |
2019-09-30 | $1.5M | 273k | 5.62 |
2019-06-30 | $2.1M | 258k | 8.03 |
2019-03-31 | $2.2M | 270k | 8.04 |
2018-12-31 | $1.2M | 288k | 4.04 |
2018-09-30 | $1.7M | 305k | 5.63 |
2018-06-30 | $3.7M | 285k | 13.13 |
2018-03-31 | $4.3M | 300k | 14.20 |
2017-12-31 | $4.6M | 560k | 8.24 |
2017-06-30 | $3.7M | 364k | 10.05 |
2017-03-31 | $2.9M | 253k | 11.65 |
2016-12-31 | $163k | 35k | 4.64 |
2016-06-30 | $1.0k | 157 | 6.37 |
2016-03-31 | $1.0k | 157 | 6.37 |
2014-12-31 | $13M | 798k | 15.84 |
2014-09-30 | $17M | 1.6M | 10.67 |
2014-06-30 | $21M | 2.3M | 9.39 |
2014-03-31 | $20M | 2.8M | 6.90 |
2013-06-30 | $73k | 12k | 6.35 |